Stakeholder cooperation in orphan drug development: The Lancet Neurology: June 6, 2016

The Lancet Neurology in conversation with - A podcast by The Lancet Group - Thursdays

Categories:

Education

Annemieke Aartsma-Rus and Elizabeth Vroom discuss with Patricia Lobo the developments in Duchenne muscular dystrophy therapy and how this can serve as a paradigm for development of treatment for rare diseases. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv